Improvement in Left Ventricular Systolic, Diastolic Performance During Ranolazine Treatment
Improvement in Left Ventricular Systolic and Diastolic Performance During Ranolazine Treatment in Patients with Stable AnginaJournal: Journal of Cardiovascular Pharmacology and Therapeutics (October 5, 2010)
Authors: Figueredo V, Pressman G, Romero-Corral A, et al
Purpose: “By preventing myocyte sodium and calcium overload, ranolazine also have potential beneficial effects on myocardial function.” Because previous research “support[s] this concept,” researchers sought to evaluate “changes in parameters of left ventricular function in stable angina patients treated with oral ranolazine.”
Results: “Global left ventricular function, as assessed by the myocardial performance index, was significantly improved on drug therapy…due to improvement in both diastolic and systolic parameters.” Out of 21 total patients, “17 reported less angina and 8 patients reported an increase in activity level.”
http://hcp.lv/cxqJqt
Comment(s)
Your comments are valuable to us. Thank you.
Sorry, you must be logged in and registered to post a comment.

American Journal of Managed Care
American Journal of Pharmacy Benefits
HCPLive
ONCLive
OTCGuide
Pharmacy Times
Physician's Money Digest
American Journal of Pharmacy Benefits
HCPLive
ONCLive
OTCGuide
Pharmacy Times
Physician's Money Digest
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747
Copyright HCPLive 2006-2011
Intellisphere, LLC. All Rights Reserved.
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747
Copyright HCPLive 2006-2011
Intellisphere, LLC. All Rights Reserved.

